anti ck19 (Santa Cruz Biotechnology)
Santa Cruz Biotechnology is a verified supplier 
95
Structured Review
Santa Cruz Biotechnology
anti ck19
Anti Ck19, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 529 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/concentration+ck19/Cytokeratin+19+Antibody/pm28126348-317-101-103
Average 95 stars, based on 529 article reviews
Anti Ck19, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 529 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/concentration+ck19/Cytokeratin+19+Antibody/pm28126348-317-101-103
Average 95 stars, based on 529 article reviews
anti ck19 - by Bioz Stars,
2026-10
95/100 stars
Images
Related Articles
Co-Immunoprecipitation Assay:Article Title: Actomyosin forces trigger a conformational change in desmoplakin within desmosomes. Article Snippet: Phalloidin AF-488 (Invitrogen) and AF-568 (Invitrogen) was used for F-actin staining. .. The following antibodies were used for the Co-IP andwestern blot experiments: Article Title: Actomyosin forces trigger a conformational change in desmoplakin within desmosomes Article Snippet: Phalloidin AF-488 (Invitrogen) and AF-568 (Invitrogen) was used for F-actin staining. .. The following antibodies were used for the Co-IP and western blot experiments: Control:Article Title: Actomyosin forces trigger a conformational change in desmoplakin within desmosomes. Article Snippet: Phalloidin AF-488 (Invitrogen) and AF-568 (Invitrogen) was used for F-actin staining. .. The following antibodies were used for the Co-IP andwestern blot experiments: Article Title: Actomyosin forces trigger a conformational change in desmoplakin within desmosomes Article Snippet: Phalloidin AF-488 (Invitrogen) and AF-568 (Invitrogen) was used for F-actin staining. .. The following antibodies were used for the Co-IP and western blot experiments: Article Title: Compositions and methods for treating serpin B13 disorders Article Snippet: Isotype controls: TIB92 (10-3.6.2, mouse mAb, ATCC, 2.3 μg/mL), rabbit polyclonal IgG (cat. no. 02-6102, Invitrogen), PE rat IgG2a kappa (eBR2a) (cat. no. 12-4321-80, eBiosciense), Alexa Fluor 488 Rat IgG2a, kappa (cat. no. 400525, Biolegend) were diluted to the same concentrations. .. IF Microscopy: Anti-serpinB13 (clone B29, mouse mAb, 10 μg/mL), anti-serpinB13 (clone B34, mouse mAb, 10 μg/mL), TIB92 (10-3.6.2, mouse Isotype control, ATCC, 10 μg/mL), Incubation:Article Title: The effect of stiffness on cell behavior and drug resistance in patient-derived breast cancer organoids. Article Snippet: Triple-negative breast cancer (TNBC) accounts for 10–15 % of breast cancer cases and is characterized by its high aggressiveness, influenced by extracellular matrix (ECM) proteins such as collagen IV and laminin.. Creating a cancer microenvironment that mimics these conditions could enhance the clinical relevance of breast cancer models for patient-specific treatments.. In this study, a Segmented Organoids with Agile Reassembly (SOAR) printing was established by compartmentalizing TNBC spheroids with ECM proteins (Matrigel®) to simulate varying levels of aggressiveness. Article Title: Long-term SiNPs exposure induced genetic instability and malignant transformation via SQSTM1/p62-mediated autophagy dysfunction in lungs Article Snippet: .. Sections were incubated overnight at 4 °C with primary antibodies against γ-H2AX (Abcam, ab81299), SQSTM1 (Abcam, ab109012), LC3B (CST, 12741), and Article Title: Key genes and histopathological alterations in hepatic fibrogenesis after segmental cholestasis in weaned rats. Article Snippet: BACKGROUND: The selective bile duct ligation (sBDL) model has been proposed to study fibrosis progression in segmental cholestasis, replicating histopathological features of biliary obstruction in both liver parenchyma with biliary obstruction (BO) and without biliary obstruction (WBO).. However, the molecular mechanisms driving fibrogenesis in WBO parenchyma remain unclear.. This study aimed to characterize gene expression and histological alterations in fibrogenesis using the sBDL model. METHODS: Liver samples were collected at 1, 4, and 8 weeks post-surgery from both BO and WBO parenchyma, undergoing histological, immunohistochemical, biochemical, and molecular analyses. Flow Cytometry:Article Title: Compositions and methods for treating serpin B13 disorders Article Snippet: Secondary antibodies: HRP-conjugated anti-sheep IgG (polyclonal donkey IgG, cat. no. HAF016, Bio-Techne, 1:1000), HRP-conjugated anti-rabbit IgG (polygoclonal goat IgG, cat. no. A27036, Invitrogen, 0.1 μg/mL) and HRP-conjugated anti-mouse IgG (rabbit polygoclonal, cat. no. A27025, Invitrogen, 0.1 g/mL). .. Flow Cytometry: Anti-serpinB13 (clone B29, mouse mAb, 2.3 μg/mL), Western Blot:Article Title: Actomyosin forces trigger a conformational change in desmoplakin within desmosomes Article Snippet: Phalloidin AF-488 (Invitrogen) and AF-568 (Invitrogen) was used for F-actin staining. .. The following antibodies were used for the Co-IP and western blot experiments: Microscopy:Article Title: Compositions and methods for treating serpin B13 disorders Article Snippet: Isotype controls: TIB92 (10-3.6.2, mouse mAb, ATCC, 2.3 μg/mL), rabbit polyclonal IgG (cat. no. 02-6102, Invitrogen), PE rat IgG2a kappa (eBR2a) (cat. no. 12-4321-80, eBiosciense), Alexa Fluor 488 Rat IgG2a, kappa (cat. no. 400525, Biolegend) were diluted to the same concentrations. .. IF Microscopy: Anti-serpinB13 (clone B29, mouse mAb, 10 μg/mL), anti-serpinB13 (clone B34, mouse mAb, 10 μg/mL), TIB92 (10-3.6.2, mouse Isotype control, ATCC, 10 μg/mL), |
